Biological Characterization and Development Workflows for Targeted Protein Degradation

DATE

January 26, 2023

TIME

8:00 a.m. PST, 11:00 a.m. EST, 16:00 GMT, 17:00 CET - Duration: 60 Minutes

Overview

Proteolysis-targeting chimeras (PROTACs) are a class of bifunctional molecules which are enabling the development of drugs against targets once considered inaccessible. PROTACs bring a protein of interest into close-proximity to an E3 ubiquitin ligase, resulting in the degradation of the target protein by the ubiquitin-proteasome system. Due to the complex mechanism of action of PROTACs, developing a clear understanding of structure-activity relationships can be quite challenging.

This webinar will focus on PROTAC biology workflows, such as in vitro screening assays, in vivo testing, and optimization of DMPK properties. Topics will include the best use of biochemical assays to measure binary/ternary complex formation, cell-based assays to assess target engagement and degradation, strategies for enhancing drug delivery and formulation, and PK/PD evaluation of PROTACs in animal models.

Key Learning Objectives:

PROTAC biology workflows, including in vitro screening assays, in vivo testing, and optimization of DMPK properties
Strategies for enhancing drug delivery and formulation
PK/PD evaluation of PROTACs in animal models

Who Should Attend:

Scientists and researchers interested in protein degradation workflows

Brought to you by:

Speakers

Kris Rutten
Director,
WuXi AppTec

Lingbing Sun
Director, Biophysics,
WuXi AppTec

Liping Ma
Senior Study Director,
WuXi AppTec

Liang Mao
Senior Director,
WuXi STA, a WuXi AppTec Company

Ann Thayer
Contributing Editor,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Address 1*

City*

State*

Zip / Post Code*

Country*

Business Phone*

Yes, we would like to learn about in vitro and in vivo assays for screening PROTACs and for uncovering structure-activity relationships

We would like to learn more about biophysical and biochemical approaches for characterizing the binding properties of PROTACs

We are interested in strategies to optimize DMPK properties of PROTACs, and how to enhance their drug delivery through improved formulations

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars